False-positive HIV nucleic acid amplification testing during CAR T-cell therapy

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Advancements in immunotherapy have opened a new era in oncology, to include genetic modification of human T-cells to express a chimeric antigen receptor (CAR) that enables targeted tumor recognition (Kochenderfer et al., 2015; Lee et al., 2015; Maus and Levine 2016; Rosenberg et al., 2008). Herein, we report a false-positive HIV testing in a patient who had undergone CAR T-cell therapy created with a lentiviral vector.

Original languageEnglish (US)
Pages (from-to)305-307
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume88
Issue number4
DOIs
StatePublished - Aug 2017

Keywords

  • CAR T-cell therapy
  • False-positive
  • HIV
  • Immunotherapy

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'False-positive HIV nucleic acid amplification testing during CAR T-cell therapy'. Together they form a unique fingerprint.

Cite this